Profil
Cheng Fang is currently Chief Scientific Officer at Annovis Bio, Inc. starting in 2026 and Assistant Professor-Research at Boston University.
Formerly, Dr. Fang was Manager-Business Development at Coriell Institute for Medical Research.
Education includes a doctorate from The Pennsylvania State University and an undergraduate degree from Nanjing University.
Postes actifs de Cheng Fang
| Sociétés | Poste | Début |
|---|---|---|
| ANNOVIS BIO, INC. | Directeur Technique/Scientifique/R&D | 18/05/2021 |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Cheng Fang
| Sociétés | Poste | Fin |
|---|---|---|
Coriell Institute for Medical Research
Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a human genome research organization | Corporate Officer/Principal | - |
Formation de Cheng Fang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Annovis Bio, Inc.
Annovis Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coriell Institute for Medical Research
Coriell Institute for Medical Research Miscellaneous Commercial ServicesCommercial Services Operates as a human genome research organization | Commercial Services |
















